Drug profile · INN
diethylcarbamazine citrate
HETRAZAN
diethylcarbamazine citrate (HETRAZAN) is a nematode gaba-a receptor positive modulator. Route of administration: oral. Current US regulatory status: approved.
Drug details — diethylcarbamazine citrate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
diethylcarbamazine citrate (HETRAZAN) is a nematode gaba-a receptor positive modulator. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Nematode GABA-A receptor positive modulator
Primary target: Nematode GABA-A receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is diethylcarbamazine citrate?
diethylcarbamazine citrate (HETRAZAN) is a nematode gaba-a receptor positive modulator. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for diethylcarbamazine citrate?
HETRAZAN is a marketed brand name for diethylcarbamazine citrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of diethylcarbamazine citrate?
diethylcarbamazine citrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.